Clinical Trial Update: Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Campath-1H with EPOCH for T-cell and NK/T-cell lymphomas has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma
• T-cell Lymphoma

Drugs mentioned

• Campath-1H (alemtuzumab)
• EPOCH

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell | Phase 2 | Status: COMPLETED | Results posted: 2016-01-21